| Literature DB >> 24570795 |
Khadija Said1, Abdallah Mkopi1, Suzanne Verver2, Fred Lwilla1, Gavin Churchyard3, Seif Shekalaghe1, Manuel Battegay4, Klaus Reither5.
Abstract
Better quality of services is essential for the sustainability of HIV programs, in particular in rural Sub-Saharan Africa, to support the increasing number of individuals treated with combination antiretroviral therapy (cART). However, longitudinal data from rural care and treatment centers (CTC) are scarce. The objective was to assess trend in quality of care for HIV infected persons before start of combination antiretroviral therapy (pre-ART). A retrospective analysis of pre-ART registers and patient's files of 1950 patients enrolled in the Bagamoyo CTC in Tanzania between 2008 and 2010 analyzing was conducted; with parameters including year of enrollment, gender, age, CD4 cell count and WHO clinical stage at time enrollment. We noted a significant increase by 20% of total patients who had CD4 cell count performed from 69% (n=457) in 2008, 83% (n=493) 2009 to 89% (n=616) 2010 (X(2)= 87.014, P(2)= 14.945, P(2)= 85.028, P(3). Efforts must be undertaken for more HIV testing and timely referral of HIV-infected patients to CTC.Entities:
Keywords: CD4 cell count; HIV; HIV treatment program; Sub-Saharan Africa; WHO clinical stage
Mesh:
Year: 2013 PMID: 24570795 PMCID: PMC3932130 DOI: 10.11604/pamj.2013.16.34.1642
Source DB: PubMed Journal: Pan Afr Med J
Baseline characteristics of participants enrolled at Bagamoyo CTC
| Characteristic | Total | Year of enrollment (N = 1950) | ||
|---|---|---|---|---|
| 2008 | 2009 | 2010 | ||
| n=663 | n=596 | n=691 | ||
|
| ||||
| Female | 1297 (67) | 440(66) | 406(68) | 451(65) |
| Male | 653 (34) | 223(34) | 190(32) | 240(35) |
|
| ||||
| Median | 35 | 34 | 35 | |
| Interquartile range | 28-42 | 28-42 | 28-44 | |
|
| ||||
| Median | 229 | 258.5 | 246.5 | |
| Interquartile range | 69-458 | 91-475 | 106-437 | |
CD4 cell count and WHO clinical stage of participants enrolled at Bagamoyo CTC. January 2008-December 2010 (N = 1950)
| Indicator | Total | 2008 | 2009 | 2010 | p-value |
|---|---|---|---|---|---|
| CD4 cell count n(%) | n=663 | n=596 | n=691 | ||
| ≤200cells/mm3 | 670 (34) | 208 (31) | 203 (34) | 259 (37) | 0.0179 |
| 200-350cells/mm3 | 337 (17) | 99 (15) | 100 (17) | 138 (20) | 0.0141 |
| >350cells/mm3 | 559 (29) | 150 (23) | 190 (32) | 219 (32) | 0.0003 |
| Not done | 384 (20) | 206 (31) | 103 (17) | 75 (11) | <0.0001 |
|
| |||||
| Stage 1 | 471 (24) | 103 (16) | 113 (19) | 255 (37) | <0.0001 |
| Stage 2 | 409 (21) | 105 (16) | 101 (17) | 203 (29) | <0.0001 |
| Stage 3 | 551 (28) | 233 (35) | 179 (30) | 139 (20) | <0.0001 |
| Stage 4 | 222 (11) | 87 (13) | 90 (15) | 45 (7) | 0.0001 |
| Missing | 297 (15) | 135 (20) | 113 (19) | 49 (7) | ---- |
p-value: chi square for linear trend